{
    "version": "https://jsonfeed.org/version/1.1",
    "title": "Μ첩ΜεΣύ Posts by Paul Rizzoli, MD Feed",
    "home_page_url": "/authors/paul-rizzoli-md",
    "feed_url": "/authors/paul-rizzoli-md/feed/json",
    "language": "en-US",
    "icon": "/img/logos/hhp-logo-mark-lg.jpg",
    "items": [{
            "id": "/blog/health-disparities-and-headache-treatment-202202152685",
            "title": "Health disparities and headache treatment",
            "url": "/blog/health-disparities-and-headache-treatment-202202152685",
            "content_html": "Migraines are a common neurologic condition, but it's estimated that in the US only about a quarter of adults with migraine are able to get an accurate diagnosis and appropriate treatment. Part of the reason for this is likely due to disparities in health care, and researchers found evidence of disparities related to race, socioeconomic status, insurance coverage, and geography.",
            "summary": "Migraines are a common neurologic condition, but it's estimated that in the US only about a quarter of adults with migraine are able to get an accurate diagnosis and appropriate treatment. Part of the reason for this is likely due to disparities in health care, and researchers found evidence of disparities related to race, socioeconomic status, insurance coverage, and geography.",
            "date_published": "2022-02-15T10:30:00-05:00",
            "date_modified": "2022-02-15T10:30:00-05:00",
                        "authors": [                { "name": "Paul Rizzoli, MD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12309/conversions/6633ae8f-5c1e-453d-8415-846d77a0458c-thumb.jpg",

            "tags": [ "Diseases & Conditions","Headache","Healthcare","Healthcare Disparities" ]
        },
        {
            "id": "/blog/lasmiditan-new-first-in-class-drug-treatment-approved-for-migraine-2019121218416",
            "title": "Lasmiditan: New first-in-class drug treatment approved for migraine",
            "url": "/blog/lasmiditan-new-first-in-class-drug-treatment-approved-for-migraine-2019121218416",
            "content_html": "The first of a new class of medications for the treatment of migraine has been approved by the FDA. Lasmiditan works differently than existing medications, and does not cause blood vessels to narrow (a side effect that makes them unsuitable for those with vascular conditions).",
            "summary": "The first of a new class of medications for the treatment of migraine has been approved by the FDA. Lasmiditan works differently than existing medications, and does not cause blood vessels to narrow (a side effect that makes them unsuitable for those with vascular conditions).",
            "date_published": "2019-12-18T00:00:00-05:00",
            "date_modified": "2019-12-18T00:00:00-05:00",
                        "authors": [                { "name": "Paul Rizzoli, MD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/9986/conversions/older-woman-holding-pill-and-glass-of-water-thumb.jpg",

            "tags": [  ]
        },
        {
            "id": "/blog/does-botox-reduce-the-frequency-of-chronic-migraine-2019091817772",
            "title": "Does Botox reduce the frequency of chronic migraine?",
            "url": "/blog/does-botox-reduce-the-frequency-of-chronic-migraine-2019091817772",
            "content_html": "People who experience chronic migraine headaches may benefit from treatment with botulimun neurotoxin (Botox), though other treatments such as medication are usually tried first.",
            "summary": "People who experience chronic migraine headaches may benefit from treatment with botulimun neurotoxin (Botox), though other treatments such as medication are usually tried first.",
            "date_published": "2019-09-18T14:30:13-04:00",
            "date_modified": "2019-09-18T14:30:13-04:00",
                        "authors": [                { "name": "Paul Rizzoli, MD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/9901/conversions/African-american-man-with-headache-thumb.jpg",

            "tags": [ "Headache" ]
        },
        {
            "id": "/blog/a-silver-lining-for-migraine-sufferers-2019032716274",
            "title": "A silver lining for migraine sufferers?",
            "url": "/blog/a-silver-lining-for-migraine-sufferers-2019032716274",
            "content_html": "",
            "summary": "",
            "date_published": "2023-10-20T00:00:00-04:00",
            "date_modified": "2023-10-20T00:00:00-04:00",
                        "authors": [                { "name": "Paul Rizzoli, MD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/9745/conversions/Migraine-and-green-light-post-thumb.jpg",

            "tags": [ "Diabetes","Headache" ]
        }        
    ]
}